Category Archives: Health

Latest From Health

Seattle Times Commentary: New Approaches Needed to Fight Ebola

scientist-eyedropper

In the Seattle Times this week, BIO Ventures for Global Health President Jennifer Dent offered commentary on the need for new drug development models to develop treatments for Ebola, arguing that conventional approaches are not working for neglected tropical diseases. Partnerships involving drug companies as well as academic, non-profit, and government stakeholders are needed. Dent offers the WIPO Re:Search consortium as an example: In 2011, BIO Ventures for Global Health established a partnership with the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Presents at 2014 Biological Weapons Convention Meeting of Experts

Palais des nations

Last week marked the annual Biological Weapons Convention (BWC) Meeting of Experts in Geneva. The BWC is a multi-national treaty prohibiting the manufacture of biological weapons, and also contains provisions related to national implementation and multi-national coordination for preparedness and assistance. Each year a Meeting of Experts takes place to discuss ongoing issues related to the implementation of the treaty. This year, for the first time ever, BIO was invited to present on novel technologies Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Forbes: Faster FDA Approvals Have Not Caused More Drug Safety Problems

FDA115x76

In 1992, Congress, industry, and the FDA worked together to create the Prescription Drug User Fee Act (PDUFA). This program ensures that FDA has the ability to hire additional reviewers to expedite the drug review process by having industry pay “user fees.” Recently, attention has been given to a flawed study in the August 2014 issue of Health Affairs, which has some critics claiming that PDUFA fees are biasing FDA review decisions. The study looked at Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

Jim Greenwood

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the Wall Street Journal, arguing that curing hepatitis C is cheaper than the alternative of open ended care. The full text of the letter is below: President and CEO of America’s Health Insurance Plans (HIP) Karen Ignagni’s “Paying for the Thousand-Dollar Pill” (op-ed, Aug. 4) plays down the fact that Sovaldi has been shown to achieve a high cure rate for Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,

Fighting Ebola with Tobacco

Ebola

Years in the making, the Ebola virus has recently erupted into a full blown health crisis. As of this week, it has claimed the lives over a thousand people – mostly in Liberia, Sierra Leone, and Guinea. Ebola is one of the world’s most virulent diseases and treating it is complicated by the fact that it is highly contagious and deadly. The infection is transmitted by direct contact with the blood, body fluids and tissues Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,